5 results on '"Joveria Farooqi"'
Search Results
2. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
- Author
-
Dania Khalid, Saeed, Joveria, Farooqi, Sadia, Shakoor, and Rumina, Hasan
- Subjects
Methicillin-Resistant Staphylococcus aureus ,Research ,Microbial Sensitivity Tests ,Infectious and parasitic diseases ,RC109-216 ,Antimicrobial resistance ,Anti-Bacterial Agents ,GLASS priority pathogens ,Infectious Diseases ,Anti-Infective Agents ,Drug Resistance, Bacterial ,Humans ,Pakistan ,Antibiogram data - Abstract
Background In 2018 Pakistan initiated its national antimicrobial resistance (AMR) surveillance aligned with Global Antimicrobial Surveillance System (GLASS). To complement this surveillance, we conducted a situational analysis of AMR rates among GLASS organisms in the country. Data from published studies and from antibiograms was compared and role of antibiograms as potential contributors to national AMR surveillance explored. Methods AMR rates for GLASS specified pathogen/antimicrobials combination from Pakistan were reviewed. Data sources included published studies (2006–2018) providing AMR rates from Pakistan (n = 54) as well as antibiograms (2011–2018) available on the Pakistan Antimicrobial Resistance Network (PARN) website. Resistance rates were categorized as follows: Very low: 0–10%, Low: 11–30%, Moderate: 30–50% and High: > 50%. Results Published data from hospital and community/laboratory-based studies report resistance rates of > 50% and 30–50% respectively to 3rd generation cephalosporins, fluoroquinolones and cotrimoxazole amongst Klebsiella pneumoniae and Escherichia coli. Carbapenem resistance rates amongst these organisms remained below 30%. High (> 50%) resistance was reported in Acinetobacter species to aminoglycosides and carbapenems among hospitalized patients. The evolution of ceftriaxone resistant Salmonella Typhi and Shigella species is reported. The data showed > 50% to fluoroquinolones amongst Neisseria gonorrhoeae and the spread of methicillin resistant Staphylococcus aureus ( 50%; 2010) in hospital settings. Resistance reported in published studies aligned well with antibiogram data. The latter also captured a clear picture of evolution of resistance over the study period. Conclusion Both published studies as well antibiograms suggest high rates of AMR in Pakistan. Antibiogram data demonstrating steady increase in AMR highlight its potential role towards supplementing national AMR surveillance efforts particularly in settings where reach of national surveillance may be limited.
- Published
- 2021
3. Serious fungal infections in Pakistan
- Author
-
David W. Denning, Kauser Jabeen, Afia Zafar, Joveria Farooqi, and Sajjad Mirza
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,Adolescent ,030106 microbiology ,Population ,Comorbidity ,Biology ,Aspergillosis ,Risk Assessment ,Young Adult ,03 medical and health sciences ,Medical microbiology ,Internal medicine ,Prevalence ,medicine ,Humans ,Pakistan ,Fungal keratitis ,Child ,education ,Aged ,Candida ,Aged, 80 and over ,education.field_of_study ,Pneumocystis ,Incidence ,Chronic pulmonary aspergillosis ,Public health ,Mucormycosis ,Infant, Newborn ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,Cryptococcus ,Aspergillus ,Infectious Diseases ,Mycoses ,Child, Preschool ,Immunology ,Female - Abstract
Introduction:The true burden of fungal infection in Pakistan is unknown. High risk populations for fungal infections (tuberculosis (TB), diabetes, chronic respiratory diseases, asthma, cancer, transplant and HIV infection) are numerous. Here we estimate the burden of fungal infections to highlight their public health significance. Methods:Whole and at risk population estimates were obtained from the WHO (TB), BREATHE study (COPD), UNAIDS (HIV), GLOBOCAN (cancer) and Heartfile (diabetes). Published data from Pakistan reporting fungal infections rates in general and specific populations was reviewed and used when applicable. Estimates were made in for the whole population, or specific populations at risk, as previously described in the LIFE methodology.Results: Of the 184,500,000 people in Pakistan, an estimated 3,280,549 (1.78%) people are affected by a serious fungal infection, omitting all cutaneous infection, oral candidiasis and allergic fungal sinusitis, which we could not estimate. Compared with other countries the rates of candidaemia (21/100,000) and mucormycosis (14/100,000) are estimated to be very high, and are based on data from India. Chronic pulmonary aspergillosis rates are estimated to be high (39/100,000) because of the high TB burden. Invasive aspergillosis was estimated to be around 5.9/100000. Fungal keratitis is also problematic in Pakistan with an estimated rate of 44/100,000. Conclusions: Pakistan probably has a high rate of certain life or sight-threatening fungal infections.
- Published
- 2017
4. Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan
- Author
-
Afia Zafar, Yusra Shafquat, Joveria Farooqi, Kiran Mehmood, Kauser Jabeen, Rumina Hasan, and Seema Irfan
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Imipenem ,Carbapenem ,Risk factors associated with resistance ,030106 microbiology ,Antimicrobial susceptibility ,Microbial Sensitivity Tests ,Drug resistance ,lcsh:Infectious and parasitic diseases ,Bacteria, Anaerobic ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Medical microbiology ,Risk Factors ,Metronidazole ,Internal medicine ,Drug Resistance, Bacterial ,Humans ,Medicine ,lcsh:RC109-216 ,Pakistan ,Pharmacology (medical) ,030212 general & internal medicine ,Anaerobic resistance to carbapenem ,business.industry ,Research ,Public Health, Environmental and Occupational Health ,Bacterial Infections ,Length of Stay ,Middle Aged ,Anti-Bacterial Agents ,Cross-Sectional Studies ,Infectious Diseases ,Carbapenems ,Population Surveillance ,Anaerobic resistance to metronidazole ,Female ,Anaerobic bacteria ,business ,Anaerobic exercise ,Anaerobic antimicrobial susceptibility ,medicine.drug - Abstract
Background Globally metronidazole and carbapenem resistance in anaerobic organisms is increasing necessitating continuous surveillance to guide selection of empirical treatment. In this study we have determined metronidazole resistance in anaerobes using MIC Evaluator strips (M.I.C.E strips). Carbapenem resistance was evaluated only in metronidazole resistant isolates. Material and methods The study was conducted at the Aga Khan University (AKU) Hospital laboratory, Karachi, Pakistan (2014–2017). Metronidazole and imipenem resistance was evaluated using M.I.C.E strips and minimum inhibitory concentrations (MICs) were interpreted using Clinical Laboratory Standards Institute (CLSI) criteria. Clinical details including demographics, prolonged hospital stay, malignancy, transplant, dialysis, diabetes, site of infection and outcome were analyzed for association with metronidazole resistance. Results Of the 223 clinically significant isolates, 39 (17.5%) were metronidazole resistant (excluding the inherently resistant organisms; for example Cutibacterium species). Imipenem resistance was determined in 29 metronidazole resistant isolates and of these 7 (24.1%) were found to be resistant. Proportion of metronidazole resistant strains was highest amongst Bacteroides species. A significant increase in metronidazole resistance from 12.3% in 2010–2011 to 17.5% in the current study was found. Carbapenem resistance also emerged in the period 2014–2017. Isolates from malignancy and transplant patients showed lower odds of developing metronidazole resistance (0.003(95% CI: 1.7–17.9)). Prolonged hospital stay was not associated with metronidazole resistance (1.1((95% CI: 0.5–2.5)). Conclusion The rising trend of metronidazole resistance and emergence of carbapenem resistance in anaerobic bacteria is alarming. Continued surveillance with strengthening of laboratory capacity regarding anaerobic susceptibility testing is urgently needed in Pakistan.
- Published
- 2019
5. Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan
- Author
-
Kausar Jabeen, Muneeba Ahsan Sayeed, Joveria Farooqi, Safia Awan, and Syed Faisal Mahmood
- Subjects
Adult ,Male ,Colonization ,0301 basic medicine ,medicine.medical_specialty ,Antifungal Agents ,Adolescent ,Candidemia, urinary tract infection ,030106 microbiology ,Single Center ,lcsh:Infectious and parasitic diseases ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Drug Resistance, Fungal ,Risk Factors ,Internal medicine ,medicine ,Ventriculitis ,Humans ,lcsh:RC109-216 ,Pakistan ,Blood culture ,030212 general & internal medicine ,Mortality ,Empyema ,Aged ,Candida ,Retrospective Studies ,Aged, 80 and over ,Voriconazole ,medicine.diagnostic_test ,business.industry ,Candidemia ,Retrospective cohort study ,Middle Aged ,Candida auris ,medicine.disease ,Survival Rate ,Logistic Models ,Infectious Diseases ,Otitis ,Female ,medicine.symptom ,business ,Fluconazole ,Research Article ,medicine.drug - Abstract
Background An outbreak of Candida auris began globally in 2014 including Pakistan and since then it has emerged as a nosocomial multi-drug resistant pathogen. The aim of this study was to assess the clinical spectrum and outcome of patients, from a single center in Pakistan, in whom C. auris was isolated. Methods A retrospective study was conducted on 92 patients; ≥16 years with at least one culture positive for C. auris, at the Aga Khan University Hospital Karachi, Pakistan from Sept 2014-Mar 2017.Demographics, clinical history, management and outcome were studied. A logistic regression model was used to identify the risk factors for mortality. Results We identified 92 patients with C. auris (193 isolates), of whom 52.2% were males. Mean age was 54.14 ± 20.4 years. Positive cultures were obtained after a median hospital stay of 14 days. Most patients had a history of surgery (57.6%), antibiotic use (95.6%), ICU stay (44.6%), indwelling lines (88.04%) and isolation of another multi-resistant organism (52.2%).Most patients were symptomatic (70.7%). Amongst these, 38 had candidemia while 27 had non-candidemia infections. Sites of infection included central lines (35), urinary tract (19), peritonitis (4), nosocomial ventriculitis (1), empyema (1), fungal keratitis (1) otitis externa (1) and surgical site (1). Fluconazole resistance was 100% while 28.5 and 7.9% were Voriconazole and Amphotericin resistant respectively. Overall crude mortality was 42.4% while 14-day mortality was 31.5%. Both infected and colonized cases shared similar mortality (46.2% vs 33.3%; p-value = 0.25). Among infected cases mortality was high in candidemia compared to non-candidemia (60.5% vs 25.9%) in which deaths related to C. auris were 34.2% vs 22.2% respectively. On multivariate analysis candidemia (AOR 4.2, 95% CI: 1.09–16.49; p-value = 0.037) was associated with greater mortality with source control being the only protective factor for mortality (AOR 0.22, 95% CI: 0.05–0.92; p-value0.038] while ICU stay, rapidity of blood culture clearance, DM, malignancy and MDR co-infection had no impact. Conclusion Patients with C.auris from a single center in Pakistan have a wide clinical spectrum with line associated infection being the predominant site of infection. Candidemia leads to high mortality while source control improves outcome.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.